Transition Bio

Operator of a biotechnology company intended to build a hypothesis-free drug discovery and diagnostics platform for human health care advancement. The company harnesses droplet microfluidic approaches...

Healthcare

Cambridge, MA, United States

Founded 2020

27 employees

Website

Valuation

$26.8M

Market implied

Share Price

N/A

Total Raised

$76.5M

Last Round

N/A

Investors

+6 other investors

View all 6 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Transition Bio's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required